Literature DB >> 16128105

[p53 gene codon 72 polymorphism and susceptibility to keloid].

Yang Zhuo1, Jian-hua Gao, Shen-qiu Luo, Wei-sen Zeng, Zhi-qi Hu, Feng Lu, Yong-zhong Zhao.   

Abstract

OBJECTIVE: To investigate the relationship between p53 codon 72 polymorphism and susceptibility to keloid in a southern Chinese population.
METHODS: The p53 genotypes were determined by polymerase chain reaction-reverse dot blot (PCR-RDB) and DNA direct sequencing in 45 patients with keloid and 60 unrelated healthy controls.
RESULTS: The frequency of the p53 Pro allele among keloid patients was significantly higher than that among healthy controls (chi2 = 4.485, P = 0.034). The Pro/Arg and Arg/Arg genotype distribution among keloid patients was not significantly different from that among healthy controls (chi2 = 0.949, 1.346; P = 0.330, 0.246, respectively). However, the Pro/Pro genotype frequency among keloid patients was significantly higher than that among healthy controls (chi2 = 4.375, P = 0.036). The p53 Pro/Pro genotype significantly increased the risk for developing keloid, compared to the combination of Pro/Arg and Arg/Arg genotypes,with the odds ratio (OR) of 2.400 (95%CI: 1.048-5.498).
CONCLUSIONS: Determination of the p53 codon 72 genotype may be used as a stratification marker to predicate high-risk individuals for keloid.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16128105

Source DB:  PubMed          Journal:  Zhonghua Zheng Xing Wai Ke Za Zhi        ISSN: 1009-4598


  2 in total

1.  Relationship between p53 gene codon-72 polymorphisms and hypertrophic scar formation following caesarean section.

Authors:  Jianhua Gao; Ying Chen; Nong Liao; Wei Zhao; Weisen Zeng; Yingtao Li; Shaojing Wang; Feng Lu
Journal:  Exp Ther Med       Date:  2014-03-05       Impact factor: 2.447

2.  Two Functional TP53 Genetic Variants and Predisposition to Keloid Scarring in Caucasians.

Authors:  Andrzej Dmytrzak; Agnieszka Boroń; Beata Łoniewska; Klaudyna Lewandowska; Iwona Gorący; Mariusz Kaczmarczyk; Andrzej Ciechanowicz
Journal:  Dermatol Res Pract       Date:  2019-11-13
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.